Jonathan Wolleben
Stock Analyst at JMP Securities
(2.48)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
LRMR Larimar Therapeutics | Maintains: Market Outperform | 22 18 | 3.79 | 374.93% | 12 | Aug 15, 2025 | |
PHVS Pharvaris | Maintains: Market Outperform | 55 52 | 20.55 | 153.04% | 12 | Aug 13, 2025 | |
ATXS Astria Therapeutics | Maintains: Market Outperform | 25 26 | 6.68 | 289.22% | 3 | Aug 13, 2025 | |
QNCX Quince Therapeutics | Maintains: Market Outperform | 9 8 | 1.58 | 406.33% | 2 | Aug 12, 2025 | |
CRNX Crinetics Pharmaceut... | Maintains: Market Outperform | 90 86 | 27.39 | 213.98% | 15 | Aug 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 67 69 | 53.77 | 28.32% | 12 | Aug 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 79 81 | 65.86 | 22.99% | 11 | Aug 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 89 87 | 17.5 | 397.14% | 10 | Aug 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 130 135 | 94.32 | 43.13% | 4 | Aug 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 25 15 | 3.38 | 343.79% | 13 | Jul 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 19 27 | 12.52 | 115.65% | 4 | Jul 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 8 8 | 1.89 | 323.28% | 7 | Jun 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 21 21 | 9.61 | 118.52% | 15 | Jun 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 15 15 | 3.52 | 326.14% | 3 | Jun 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 19 19 | 6.82 | 178.59% | 9 | May 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 5 5 | n/a | n/a | 11 | May 16, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 443 443 | 349.43 | 26.78% | 12 | Apr 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Outperform | 38 | 11.2 | 239.29% | 1 | Apr 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 22 19 | 12.56 | 51.27% | 17 | Mar 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 18 18 | 8.2 | 119.51% | 8 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 9 9 | 2.71 | 232.1% | 8 | Dec 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 55 50 | 43.49 | 14.97% | 1 | Dec 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 90 90 | 92.51 | -2.71% | 1 | Dec 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Perform | n/a | n/a | n/a | 1 | Dec 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 225 225 | 9.98 | 2154.51% | 7 | Dec 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Accumulate | 420 485 | 689.22 | -29.63% | 1 | Nov 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 3 3 | n/a | n/a | 6 | Sep 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 48 32 | 8.72 | 266.97% | 8 | Aug 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 8 8 | 0.49 | 1532.65% | 11 | Apr 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 25 24 | 31.65 | -24.17% | 1 | May 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | May 25, 2021 |